XXII Stock Summary and Trading Ideas (22Nd Century Group | NASDAQ:XXII)

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

22Nd Century Group trades on the NASDAQ stock market under the symbol XXII.

As of February 13, 2026, XXII stock price climbed to $6.43 with 131,883 million shares trading.

XXII has a beta of 2.57, meaning it tends to be more sensitive to market movements. XXII has a correlation of 0.03 to the broad based SPY ETF.

XXII has a market cap of $3.28 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, XXII traded as high as $782,503.80 and as low as $.67.

XXII has underperformed the market in the last year with a price return of -91.0% while the SPY ETF gained +13.0%. However, in the short term, XXII had mixed performance relative to the market. It has outperformed in the last 3 months, returning +506.6% vs +1.7% return in SPY. But in the last 2 weeks, XXII shares have been beat by the market, returning -16.3% compared to an SPY return of -1.5%.

XXII support price is $5.18 and resistance is $6.20 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that XXII shares will trade within this expected range on the day.